168 related articles for article (PubMed ID: 22284584)
41. Repairing cartilage defects with bone marrow mesenchymal stem cells induced by CDMP and TGF-β1.
Wu G; Cui Y; Ma L; Pan X; Wang X; Zhang B
Cell Tissue Bank; 2014 Mar; 15(1):51-7. PubMed ID: 23460257
[TBL] [Abstract][Full Text] [Related]
42. The effect of TGF-beta1 and beta-estradiol on glycosaminoglycan and type II collagen distribution in articular chondrocyte cultures.
Ab-Rahim S; Selvaratnam L; Kamarul T
Cell Biol Int; 2008 Jul; 32(7):841-7. PubMed ID: 18479947
[TBL] [Abstract][Full Text] [Related]
43. The effects of TGF-beta1 and IGF-I on the biomechanics and cytoskeleton of single chondrocytes.
Leipzig ND; Eleswarapu SV; Athanasiou KA
Osteoarthritis Cartilage; 2006 Dec; 14(12):1227-36. PubMed ID: 16824771
[TBL] [Abstract][Full Text] [Related]
44. Cellulose-based scaffold materials for cartilage tissue engineering.
Müller FA; Müller L; Hofmann I; Greil P; Wenzel MM; Staudenmaier R
Biomaterials; 2006 Jul; 27(21):3955-63. PubMed ID: 16530823
[TBL] [Abstract][Full Text] [Related]
45. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering.
Park H; Temenoff JS; Tabata Y; Caplan AI; Mikos AG
Biomaterials; 2007 Jul; 28(21):3217-27. PubMed ID: 17445882
[TBL] [Abstract][Full Text] [Related]
46. Dedifferentiation and redifferentiation of articular chondrocytes from surface and middle zones: changes in microRNAs-221/-222, -140, and -143/145 expression.
Hong E; Reddi AH
Tissue Eng Part A; 2013 Apr; 19(7-8):1015-22. PubMed ID: 23190381
[TBL] [Abstract][Full Text] [Related]
47. Type II collagen modulates the composition of extracellular matrix synthesized by articular chondrocytes.
Qi WN; Scully SP
J Orthop Res; 2003 Mar; 21(2):282-9. PubMed ID: 12568960
[TBL] [Abstract][Full Text] [Related]
48. Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model.
Moretti M; Wendt D; Dickinson SC; Sims TJ; Hollander AP; Kelly DJ; Prendergast PJ; Heberer M; Martin I
Tissue Eng; 2005; 11(9-10):1421-8. PubMed ID: 16259597
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms of chondrocyte adhesion to cartilage: role of beta1-integrins, CD44, and annexin V.
Kurtis MS; Tu BP; Gaya OA; Mollenhauer J; Knudson W; Loeser RF; Knudson CB; Sah RL
J Orthop Res; 2001 Nov; 19(6):1122-30. PubMed ID: 11781014
[TBL] [Abstract][Full Text] [Related]
50. Influence of temporary chondroitinase ABC-induced glycosaminoglycan suppression on maturation of tissue-engineered cartilage.
Bian L; Crivello KM; Ng KW; Xu D; Williams DY; Ateshian GA; Hung CT
Tissue Eng Part A; 2009 Aug; 15(8):2065-72. PubMed ID: 19196151
[TBL] [Abstract][Full Text] [Related]
51. Inducing chondrogenic differentiation in injectable hydrogels embedded with rabbit chondrocytes and growth factor for neocartilage formation.
Yun K; Moon HT
J Biosci Bioeng; 2008 Feb; 105(2):122-6. PubMed ID: 18343338
[TBL] [Abstract][Full Text] [Related]
52. The involvement of beta1 integrin in the modulation by collagen of chondrocyte-response to transforming growth factor-beta1.
Lee JW; Qi WN; Scully SP
J Orthop Res; 2002 Jan; 20(1):66-75. PubMed ID: 11853092
[TBL] [Abstract][Full Text] [Related]
53. TGF-beta1 immobilized tri-co-polymer for articular cartilage tissue engineering.
Chou CH; Cheng WT; Lin CC; Chang CH; Tsai CC; Lin FH
J Biomed Mater Res B Appl Biomater; 2006 May; 77(2):338-48. PubMed ID: 16470812
[TBL] [Abstract][Full Text] [Related]
54. Biodegradable chitosan scaffolds containing microspheres as carriers for controlled transforming growth factor-beta1 delivery for cartilage tissue engineering.
Cai DZ; Zeng C; Quan DP; Bu LS; Wang K; Lu HD; Li XF
Chin Med J (Engl); 2007 Feb; 120(3):197-203. PubMed ID: 17355821
[TBL] [Abstract][Full Text] [Related]
55. Stimulation of Superficial Zone Protein/Lubricin/PRG4 by Transforming Growth Factor-β in Superficial Zone Articular Chondrocytes and Modulation by Glycosaminoglycans.
Cuellar A; Reddi AH
Tissue Eng Part A; 2015 Jul; 21(13-14):1973-81. PubMed ID: 25398329
[TBL] [Abstract][Full Text] [Related]
56. Bioimaging of dexamethasone and TGF beta-1 and its biological activities of chondrogenic differentiation in hydrogel constructs.
Na K; Kim S; Sun BK; Woo DG; Yang HN; Chung HM; Park KH
J Biomed Mater Res A; 2008 Nov; 87(2):283-9. PubMed ID: 18181092
[TBL] [Abstract][Full Text] [Related]
57. [In vitro study on induction systems for marrow mesenchymal stem cells to chondrocytes].
Yan J; Li L; Zhang Q
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Nov; 20(11):1114-8. PubMed ID: 17191580
[TBL] [Abstract][Full Text] [Related]
58. In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells.
Wang Y; Kim UJ; Blasioli DJ; Kim HJ; Kaplan DL
Biomaterials; 2005 Dec; 26(34):7082-94. PubMed ID: 15985292
[TBL] [Abstract][Full Text] [Related]
59. In vitro engineering of cartilage: effects of serum substitutes, TGF-beta, and IL-1alpha.
Glowacki J; Yates KE; Maclean R; Mizuno S
Orthod Craniofac Res; 2005 Aug; 8(3):200-8. PubMed ID: 16022722
[TBL] [Abstract][Full Text] [Related]
60. Cell yield, proliferation, and postexpansion differentiation capacity of human ear, nasal, and rib chondrocytes.
Tay AG; Farhadi J; Suetterlin R; Pierer G; Heberer M; Martin I
Tissue Eng; 2004; 10(5-6):762-70. PubMed ID: 15265293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
